Global Cord Blood ( (CORBF) ) has released a notification of late filing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Global Cord Blood Corporation has announced a delay in filing its Annual Report on Form 20-F (Yearly Report) for the fiscal year ending March 31, 2025. The delay is primarily due to ongoing investigations by joint provisional liquidators into the company’s financial position, which have been in place since a court order in September 2022. The company has not provided a specific timeline for when the 2025 Annual Report will be filed. The company anticipates significant changes in financial results but cannot currently estimate the extent of these changes due to the ongoing investigations. Global Cord Blood Corporation is working to comply with regulatory requirements, as indicated by the signature of John Royle, Joint Provisional Liquidator, on the notification.
More about Global Cord Blood
Average Trading Volume: 20,141
Technical Sentiment Signal: Strong Sell
Current Market Cap: $73.65M
Learn more about CORBF stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money